Abstract
Chiral derivatization with an enantiomerically pure reagent is an economical and effective way to separate the enantiomers of optically active drugs on achiral HPLC columns. This paper describes the preparation and analytical testing of two novel chiral derivatizing agents (CDAs) deriving from the 2-arylpropionic acid (S)-(+)-naproxen, viz., 1-(6-methoxy-2-naphthyl)ethyl isothiocyanate (NAP-IT) and 2-(6-methoxy-2-naphthyl)-1-propyl chloroformate (NAP-C). Both are suitable reagents for the derivatization of amino compounds (e.g., β-adrenoceptor antagonists, antiarrhythmic agents). The diastereomeric derivatives of these chiral drugs are resolved on reversed-phase HPLC columns and/or silica gel stationary phases. The high UV absorbance and an additional intrinsic fluorescence of both CDAs facilitates the detection of the derivatization products.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
